Clinical trial
SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus
NCT00371826 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00371826 |
|---|---|
| Title | SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus |
| Official title | A Prospective, Open-label, Controlled Multicenter Trial to Assess the Efficacy and Safety of an Induction Regimen of Cyclosporine Micro Emulsion, Enteric-coated Mycophenolate Sodium (EC-MPS) and Corticosteroids, Followed by Administration of Everolimus and Enteric-coated Mycophenolate Sodium… |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Renal Transplanted Recipients |
| Intervention type | Drug |
| Interventions | Everolimus (RAD001), Cyclosporine (Calcineurin Inhibitor (CNI)), Methylprednisone/prednisone, Mycophenolate sodium (MPA) |
| Enrollment | 126 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Sep 4, 2006 |
| Last update posted | Aug 19, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: